GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trevena Inc (NAS:TRVN) » Definitions » Shiller PE Ratio

Trevena (Trevena) Shiller PE Ratio : (As of Jun. 03, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Trevena Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Trevena Shiller PE Ratio Historical Data

The historical data trend for Trevena's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trevena Shiller PE Ratio Chart

Trevena Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Trevena Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Trevena's Shiller PE Ratio

For the Biotechnology subindustry, Trevena's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trevena's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trevena's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Trevena's Shiller PE Ratio falls into.



Trevena Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Trevena's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Trevena's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.36/131.7762*131.7762
=-0.360

Current CPI (Mar. 2024) = 131.7762.

Trevena Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -11.000 100.560 -14.415
201409 -14.750 100.428 -19.354
201412 -11.000 99.070 -14.631
201503 -8.250 99.621 -10.913
201506 -7.000 100.684 -9.162
201509 -6.000 100.392 -7.876
201512 -7.500 99.792 -9.904
201603 -8.750 100.470 -11.476
201606 -9.250 101.688 -11.987
201609 -14.250 101.861 -18.435
201612 -16.750 101.863 -21.669
201703 -9.000 102.862 -11.530
201706 -8.750 103.349 -11.157
201709 -6.750 104.136 -8.542
201712 -5.750 104.011 -7.285
201803 -3.500 105.290 -4.380
201806 -3.250 106.317 -4.028
201809 -1.500 106.507 -1.856
201812 -2.500 105.998 -3.108
201903 -1.500 107.251 -1.843
201906 -1.250 108.070 -1.524
201909 -2.250 108.329 -2.737
201912 -1.750 108.420 -2.127
202003 -1.500 108.902 -1.815
202006 -1.500 108.767 -1.817
202009 -1.000 109.815 -1.200
202012 -2.000 109.897 -2.398
202103 -1.500 111.754 -1.769
202106 -2.250 114.631 -2.587
202109 -2.000 115.734 -2.277
202112 -2.000 117.630 -2.241
202203 -2.480 121.301 -2.694
202206 -2.260 125.017 -2.382
202209 -2.240 125.227 -2.357
202212 -0.730 125.222 -0.768
202303 -0.810 127.348 -0.838
202306 -0.690 128.729 -0.706
202309 -0.570 129.860 -0.578
202312 -1.130 129.419 -1.151
202403 -0.360 131.776 -0.360

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Trevena  (NAS:TRVN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Trevena Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Trevena's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Trevena (Trevena) Business Description

Traded in Other Exchanges
Address
955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA, USA, 19087
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Executives
Mark Corrigan director
Mark Demitrack officer: SVP, Chief Medical Officer 955 CHESTERBROOK BOULEVARD, SUITE 200, CHESTERBROOK PA 19087
Robert T Yoder officer: SVP, Chief Business Officer 955 CHESTERBROOK BOULEVARD, SUITE 110, SUITE 200, CHESTERBROOK PA 19087
Carrie L. Bourdow director, officer: President & CEO C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Patricia M. Drake officer: SVP, Chief Commercial Officer 245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142
Barry Shin officer: SVP, CFO C/O TREVENA, INC., 955 CHESTERBROOK BLVD, SUITE 110, CHESTERBROOK PA 19087
Marvin Johnson director C/O TREVENA, INC., 955 CHESTERBROOK BOULEVARD, STE. 110, CHESTERBROOK PA 19087
Barbara Yanni director 1018 W. 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Moulder Leon O Jr director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jason Raleigh Nunn director 1119 ST. PAUL STREET, BALTIMORE MD 21202
Scott Braunstein director C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR MI 48108
Michael R Dougherty director C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341
Anne M. Phillips director C/O TREVENA, INC., 1018 WEST 8TH AVENUE, KING OF PRUSSIA PA 19406
Scott Applebaum officer: CLCO; SVP, Regulatory Affairs C/O TREVENA INC., 955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK PA 19087
John P. Hamill officer: Int. Prin. Fin. Off. and PAO 4092 NEW HOPE ROAD, FURLONG PA 18925